ICD-10-CM Billable Code

I70.513

Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, bilateral legs

Clinical Classification Guidelines

Medical Intelligence & Overview

Atherosclerosis of nonautologous biological bypass grafts in the extremities is a condition where fatty deposits build up inside the blood vessels used to bypass blocked arteries in the legs. This condition often affects both legs, causing a restriction of blood flow that can lead to intermittent claudication—a type of leg pain during physical activity that subsides with rest. It is a significant concern for individuals who have undergone surgical procedures to restore blood circulation to their legs.

Causes & Symptoms

Clinical Causes: Progressive buildup of fatty deposits (plaque) inside blood vessels, leading to narrowing and hardening (atherosclerosis). Degeneration or failure of previous bypass grafts, especially if biological materials are used instead of synthetic options. Lifestyle factors such as smoking, unhealthy diet, physical inactivity, and obesity. Chronic conditions like high blood pressure, high cholesterol levels, and diabetes mellitus. Age-related changes in blood vessel walls, making them more susceptible to atherosclerosis. Genetic predispositions affecting cholesterol and vascular health.

Key Symptoms: Intermittent claudication—a cramping or aching pain in the legs during walking or exertion that improves with rest. Weakness or numbness in the legs. Coolness or pallor of the skin on the affected legs or feet. Skin changes such as dryness, hair loss, or shiny skin on the legs. In advanced cases, ulcers or gangrene may develop on the toes, heels, or other areas of the feet. Difficulties with wound healing on the lower extremities.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a thorough medical history review, physical examination, and specialized tests such as Doppler ultrasound, ankle-brachial index (ABI), angiography, or magnetic resonance angiography (MRA). These help evaluate blood flow and identify blockages in the vessels or grafts. Healthcare providers also assess risk factors like cholesterol levels, blood pressure, and blood sugar to form a comprehensive understanding of the individual's vascular health.

Treatment Protocols: Managing this condition involves a combination of lifestyle changes, medical therapy, and potentially surgical interventions. Common approaches include: - Lifestyle modifications such as quitting smoking, adopting a balanced diet low in saturated fats, maintaining a healthy weight, and engaging in regular, supervised exercise programs. - Medications to control cholesterol levels, blood pressure, and blood sugar, as well as antiplatelet agents to prevent blood clots. - Close monitoring of graft function through imaging studies. - In some cases, minimally invasive procedures or additional surgical interventions may be necessary to open blocked grafts or bypass narrowed vessels. - Ongoing management to reduce overall cardiovascular risk and prevent disease progression.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is I70.513 a billable ICD-10 code?
Yes, I70.513 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report I70.513?
Clinical documentation must specify the nature of Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, bilateral legs and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

nonautologous bilateral intermittent atherosclerosis bypass biological extremities